NeoSense_564 is a series a startup based in France. 1 investor tracked on Brouky Intelligence. Status: dead. Data sourced from Brouky Intelligence.
About
Developed a non-invasive medical device for continuous monitoring of cerebral oxygenation in newborns at risk of brain injury.
Stage
series-a
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky